MA41943A - Polypeptides ciblant une fusion du vih - Google Patents
Polypeptides ciblant une fusion du vihInfo
- Publication number
- MA41943A MA41943A MA041943A MA41943A MA41943A MA 41943 A MA41943 A MA 41943A MA 041943 A MA041943 A MA 041943A MA 41943 A MA41943 A MA 41943A MA 41943 A MA41943 A MA 41943A
- Authority
- MA
- Morocco
- Prior art keywords
- fusion polypeptides
- hiv fusion
- hiv
- polypeptides
- fusion
- Prior art date
Links
- 230000004927 fusion Effects 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
- A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- AIDS & HIV (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Immunology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562152271P | 2015-04-24 | 2015-04-24 | |
US201562257474P | 2015-11-19 | 2015-11-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
MA41943A true MA41943A (fr) | 2018-02-28 |
Family
ID=55809237
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA056222A MA56222A (fr) | 2015-04-24 | 2016-04-14 | Polypeptides ciblant une fusion du vih |
MA041943A MA41943A (fr) | 2015-04-24 | 2016-04-14 | Polypeptides ciblant une fusion du vih |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MA056222A MA56222A (fr) | 2015-04-24 | 2016-04-14 | Polypeptides ciblant une fusion du vih |
Country Status (25)
Country | Link |
---|---|
US (2) | US10407490B2 (fr) |
EP (2) | EP3985020A1 (fr) |
JP (3) | JP6894846B2 (fr) |
KR (1) | KR20170138558A (fr) |
CN (1) | CN107922474A (fr) |
AU (2) | AU2016252008B2 (fr) |
BR (1) | BR112017022790A2 (fr) |
CA (1) | CA2983276A1 (fr) |
CL (1) | CL2017002687A1 (fr) |
CO (1) | CO2017011583A2 (fr) |
CR (1) | CR20170482A (fr) |
DO (1) | DOP2017000246A (fr) |
EA (1) | EA035332B1 (fr) |
ES (1) | ES2884267T3 (fr) |
HK (1) | HK1243432A1 (fr) |
IL (1) | IL255122A0 (fr) |
MA (2) | MA56222A (fr) |
MX (1) | MX2017013687A (fr) |
PE (1) | PE20180162A1 (fr) |
PH (1) | PH12017501914A1 (fr) |
PT (1) | PT3286212T (fr) |
SG (1) | SG11201708441RA (fr) |
TW (1) | TW201643185A (fr) |
UY (1) | UY36650A (fr) |
WO (1) | WO2016171980A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106755100A (zh) * | 2017-02-20 | 2017-05-31 | 李因传 | 可控性hiv‑1基因组靶向编辑系统和其靶向载运系统 |
WO2019123262A1 (fr) | 2017-12-18 | 2019-06-27 | VIIV Healthcare UK (No.5) Limited | Polypeptides de liaison à un antigène |
CN108997482A (zh) * | 2018-08-09 | 2018-12-14 | 东莞市朋志生物科技有限公司 | 用于检测hiv-1的合成肽 |
WO2021081515A2 (fr) * | 2019-10-25 | 2021-04-29 | Cidara Therapeutics, Inc. | Compositions et procédés pour le traitement du virus de l'immunodéficience humaine |
CN117980465A (zh) * | 2021-08-30 | 2024-05-03 | 康霖生物科技(杭州)有限公司 | 一种用于艾滋病病毒感染基因治疗的基因序列构建体 |
Family Cites Families (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3773919A (en) | 1969-10-23 | 1973-11-20 | Du Pont | Polylactide-drug mixtures |
USRE30985E (en) | 1978-01-01 | 1982-06-29 | Serum-free cell culture media | |
US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
US4657866A (en) | 1982-12-21 | 1987-04-14 | Sudhir Kumar | Serum-free, synthetic, completely chemically defined tissue culture media |
US4767704A (en) | 1983-10-07 | 1988-08-30 | Columbia University In The City Of New York | Protein-free culture medium |
US5672502A (en) | 1985-06-28 | 1997-09-30 | Celltech Therapeutics Limited | Animal cell culture |
US4927762A (en) | 1986-04-01 | 1990-05-22 | Cell Enterprises, Inc. | Cell culture medium with antioxidant |
US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
FR2646437B1 (fr) | 1989-04-28 | 1991-08-30 | Transgene Sa | Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant |
JP3051145B2 (ja) | 1990-08-28 | 2000-06-12 | 住友製薬株式会社 | 新規なポリエチレングリコール誘導体修飾ペプチド |
US5122469A (en) | 1990-10-03 | 1992-06-16 | Genentech, Inc. | Method for culturing Chinese hamster ovary cells to improve production of recombinant proteins |
PL174721B1 (pl) | 1992-11-13 | 1998-09-30 | Idec Pharma Corp | Przeciwciało monoklonalne anty-CD20 |
US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
US6261804B1 (en) | 1997-01-21 | 2001-07-17 | The General Hospital Corporation | Selection of proteins using RNA-protein fusions |
KR100566859B1 (ko) | 1997-01-21 | 2006-04-03 | 제너럴 하스피톨 코포레이션 | Rna-단백질 융합물을 이용한 단백질의 선별 |
US6818418B1 (en) | 1998-12-10 | 2004-11-16 | Compound Therapeutics, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
WO2001043779A2 (fr) * | 1999-12-16 | 2001-06-21 | Tanox, Inc. | Conjugues anti-hiv1 pour le traitement du vih |
US20050287153A1 (en) | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
CA2416219C (fr) | 2000-07-11 | 2016-10-11 | Research Corporation Technologies, Inc. | Polypeptides d'anticorps artificiels |
US7696320B2 (en) | 2004-08-24 | 2010-04-13 | Domantis Limited | Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor |
US20060121480A1 (en) * | 2002-09-27 | 2006-06-08 | Tanox, Inc. | Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
ES2655912T3 (es) | 2002-11-08 | 2018-02-22 | Ablynx N.V. | Anticuerpos de dominio simple dirigidos contra factor de necrosis tumoral-alfa y usos para los mismos |
EP1729795B1 (fr) | 2004-02-09 | 2016-02-03 | Human Genome Sciences, Inc. | Proteines hybrides d'albumine |
US20070269422A1 (en) | 2006-05-17 | 2007-11-22 | Ablynx N.V. | Serum albumin binding proteins with long half-lives |
US20090022720A1 (en) | 2007-07-20 | 2009-01-22 | Stephan Fischer | Conjugate of an antibody against CD4 and antifusogenic peptides |
EA201000979A1 (ru) | 2007-12-27 | 2011-02-28 | Новартис Аг | Улучшенные связывающие молекулы на основе фибронектина и их применение |
BRPI0913007A2 (pt) | 2008-05-02 | 2019-09-24 | Novartis Ag | moléculas de ligação aprimoradas à base de fibronectina e usos das mesmas |
PL2356269T3 (pl) | 2008-10-31 | 2016-12-30 | Kompozycje białek rusztowania oparte na domenie fibronektyny typu III, sposoby i zastosowania | |
GB0920944D0 (en) * | 2009-11-30 | 2010-01-13 | Biotest Ag | Agents for treating disease |
EP2516459A1 (fr) | 2009-12-22 | 2012-10-31 | Aarhus Universitet (University Of Aarhus) | Molécules bivalentes destinées à inhiber l'entrée du vih |
CA2796338C (fr) | 2010-04-13 | 2020-03-24 | Bristol-Myers Squibb Company | Proteines a domaine de squelette base sur la fibronectine qui se lient a pcsk9 |
TW201138808A (en) * | 2010-05-03 | 2011-11-16 | Bristol Myers Squibb Co | Serum albumin binding molecules |
CN102939538A (zh) * | 2010-05-07 | 2013-02-20 | 霍夫曼-拉罗奇有限公司 | 用于离体检测细胞的诊断方法 |
EP2655411A1 (fr) | 2010-12-22 | 2013-10-30 | Bristol-Myers Squibb Company | Protéines à domaine échafaudage à base de fibronectine qui se lient à l'il-23 |
US9880151B2 (en) | 2011-05-23 | 2018-01-30 | Phylogica Limited | Method of determining, identifying or isolating cell-penetrating peptides |
BR112014007469B1 (pt) | 2011-09-27 | 2022-06-14 | Janssen Biotech, Inc | Método de fabricação de uma biblioteca de domínios de módulo de fibronectina tipo iii (fn3), biblioteca e método para obter um arcabouço de proteína |
WO2014120891A2 (fr) * | 2013-02-01 | 2014-08-07 | Bristol-Myers Squibb Company | Protéines d'échafaudage à base de fibronectine |
WO2014165093A2 (fr) * | 2013-03-13 | 2014-10-09 | Bristol-Myers Squibb Company | Domaines d'échafaudage à base de fibronectine liés à une sérum albumine ou fragment se liant à celle-ci |
CN103333255A (zh) | 2013-06-28 | 2013-10-02 | 复旦大学 | 一种长效hiv‐1膜融合抑制剂 |
-
2016
- 2016-04-14 EP EP21176464.2A patent/EP3985020A1/fr active Pending
- 2016-04-14 PT PT167188176T patent/PT3286212T/pt unknown
- 2016-04-14 EP EP16718817.6A patent/EP3286212B1/fr active Active
- 2016-04-14 US US15/568,830 patent/US10407490B2/en active Active
- 2016-04-14 MX MX2017013687A patent/MX2017013687A/es unknown
- 2016-04-14 MA MA056222A patent/MA56222A/fr unknown
- 2016-04-14 MA MA041943A patent/MA41943A/fr unknown
- 2016-04-14 CN CN201680036930.XA patent/CN107922474A/zh active Pending
- 2016-04-14 SG SG11201708441RA patent/SG11201708441RA/en unknown
- 2016-04-14 KR KR1020177033985A patent/KR20170138558A/ko unknown
- 2016-04-14 AU AU2016252008A patent/AU2016252008B2/en not_active Ceased
- 2016-04-14 EA EA201792269A patent/EA035332B1/ru not_active IP Right Cessation
- 2016-04-14 CR CR20170482A patent/CR20170482A/es unknown
- 2016-04-14 JP JP2017555557A patent/JP6894846B2/ja active Active
- 2016-04-14 BR BR112017022790-8A patent/BR112017022790A2/pt not_active IP Right Cessation
- 2016-04-14 WO PCT/US2016/027424 patent/WO2016171980A1/fr active Application Filing
- 2016-04-14 ES ES16718817T patent/ES2884267T3/es active Active
- 2016-04-14 CA CA2983276A patent/CA2983276A1/fr not_active Abandoned
- 2016-04-14 PE PE2017002311A patent/PE20180162A1/es unknown
- 2016-04-22 TW TW105112708A patent/TW201643185A/zh unknown
- 2016-04-22 UY UY0001036650A patent/UY36650A/es not_active Application Discontinuation
-
2017
- 2017-10-18 IL IL255122A patent/IL255122A0/en unknown
- 2017-10-19 PH PH12017501914A patent/PH12017501914A1/en unknown
- 2017-10-23 CL CL2017002687A patent/CL2017002687A1/es unknown
- 2017-10-23 DO DO2017000246A patent/DOP2017000246A/es unknown
- 2017-11-14 CO CONC2017/0011583A patent/CO2017011583A2/es unknown
-
2018
- 2018-02-28 HK HK18102882.7A patent/HK1243432A1/zh unknown
-
2019
- 2019-08-07 US US16/533,941 patent/US11155602B2/en active Active
- 2019-09-06 AU AU2019226255A patent/AU2019226255A1/en not_active Abandoned
-
2020
- 2020-10-16 JP JP2020174288A patent/JP2021035951A/ja active Pending
-
2023
- 2023-02-03 JP JP2023014947A patent/JP7465378B2/ja active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3292141T3 (da) | Fusionsproteiner | |
DK3180363T3 (da) | Sirp-alpha-immunoglobulin fusionsproteiner | |
DK4089113T3 (da) | Polypeptider | |
DK3197453T3 (da) | Kimært protein | |
DK3365563T3 (da) | Forbindelseskomponent | |
DK3107562T3 (da) | P97-ids-fusionsproteiner | |
DK3362444T3 (da) | Forbindelser | |
MA41943A (fr) | Polypeptides ciblant une fusion du vih | |
FI20155191A (fi) | Nivel | |
BR112016029235A2 (pt) | Polipeptídeos de fusão relacionados com ômega- hidroxilase com propriedades aprimoradas | |
DK3126521T3 (da) | HNF4G-RSPO2-fusionsgen | |
FR3021224B1 (fr) | Phytomedicament pour le vih | |
DK3331885T3 (da) | Forbindelser | |
DK3310756T3 (da) | Thromboxanreceptorantagonister | |
DK3436447T3 (da) | Isoquinolinyl-triazolon-komplekser | |
ES1202236Y (es) | Bombona | |
ITUA20162057A1 (it) | Natante | |
BR112017003965A2 (pt) | polipeptídeos vip3 modificados | |
DK3302527T3 (da) | Manipuleret CCL20-låst-dimerpolypeptid | |
ITUA20162867A1 (it) | Interruttore differenziale | |
ES2775740T8 (es) | Péptidos | |
UA33793S (uk) | Вимикач | |
DE112016001702A5 (de) | Gelenkanordnung | |
ES1153858Y (es) | Antorcha hidroneumatica | |
UA33641S (uk) | Вимикач |